Estimating chlamydia screening coverage: A comparison of self-report and health care effectiveness data and information set measures

Sexually Transmitted Diseases

Volumn 41, Issue 11, 2014, Pages 665-670

  Khosropour, Christine M ^a   Broad, Jennifer M ^a   Scholes, Delia ^a,b   Saint Johnson, Jacquelyn ^b   Manhart, Lisa E ^a,c   Golden, Matthew R ^a,d,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b GROUP HEALTH RESEARCH INSTITUTE   (United States)

^c Department of Global Health ^*  (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHLAMYDIASIS; COMPARATIVE STUDY; DATA ANALYSIS; FEMALE; GOLD STANDARD; HEALTH CARE; HEALTH INSURANCE; HUMAN; INFORMATION SERVICE; MANAGED CARE ORGANIZATION; OUTCOME ASSESSMENT; SCREENING; SELF REPORT; SENSITIVITY AND SPECIFICITY; SEXUAL BEHAVIOR; UNITED STATES; VALIDITY; YOUNG ADULT; ADOLESCENT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FACTUAL DATABASE; HEALTH SERVICE; ISOLATION AND PURIFICATION; MASS SCREENING; QUESTIONNAIRE; REPRODUCIBILITY; SENTINEL SURVEILLANCE; STATISTICS AND NUMERICAL DATA; THEORETICAL MODEL; VALIDATION STUDY;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DATABASES, FACTUAL; FEMALE; HUMANS; INSURANCE, HEALTH; MASS SCREENING; MODELS, THEORETICAL; REPRODUCIBILITY OF RESULTS; REPRODUCTIVE HEALTH SERVICES; SELF REPORT; SENTINEL SURVEILLANCE; SURVEYS AND QUESTIONNAIRES; UNITED STATES; WASHINGTON;

EID: 84929464312     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0000000000000186     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2012. Atlanta, GA: US Department of Health and Human Services, 2013.
2. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010; 59:1-110.
3. Meyers DS, Halvorson H, Luckhaupt S, et al. Screening for chla-mydial infection: an evidence update for the U.S. Preventive Services Task Force. Ann Intern Med 2007; 147:135-142.
4. American Congress on Obstetricians and Gynecologists. Chlamydia and Gonorrhea Screening a Must for Women 25 and Younger. 2013. Available at: http://acogpresident.org/2013/04/11/chlamydia-and-gonorrhea-screening-a-must-for-women-25-and-younger/. Accessed December 3, 2013.
5. Bright Futures/American Academy of Pediatrics. Recommendations for Preventative Pediatric Health Care. 2008. Available at: http://brightfutures.aap.org/pdfs/AAP-Bright-Futures-Periodicity-Sched- 101107.pdf. Accessed December 4, 2013.
6. - 1993 Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR Recomm Rep 1993; 42:1-102.
7. Centers for Disease C, Prevention. CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morbid Mortal Wkly Rep. 2011; 60:370-373.
8. Tao G, Hoover KW, Leichliter JS, et al. Self-reported chlamydia testing rates of sexually active women aged 15-25 years in the United States, 2006-2008. Sex Transm Dis 2012; 39:605-607.
9. Tao G, Hoover KW, Kent CK. Chlamydia testing patterns for commercially insured women, 2008. Am J Prev Med 2012; 42:337-341.
10. Heijne JC, Tao G, Kent CK, et al. Uptake of regular chlamydia testing by U.S. women: A longitudinal study. Am J Prev Med 2010; 39:243-250.
11. Levine WC, Dicker LW, Devine O, et al. Indirect estimation of chlamydia screening coverage using public health surveillance data. Am J Epidemiol 2004; 160:91-96.
12. Broad JM, Manhart LE, Kerani RP, et al. Chlamydia screening coverage estimates derived using healthcare effectiveness data and information system procedures and indirect estimation vary substantially. Sex Transm Dis 2013; 40:292-297.
13. National Committee for Quality Assurance. The State of Health Care Quality, 2012. 2012. Available at: http://www.ncqa.org/Portals/0/State%20of%20Health%20Care/2012/SOHC%20Report%20Web.pdf. Accessed December 3, 2013.
14. Tao G, Walsh CM, Anderson LA, et al. Understanding sexual activity defined in the HEDIS measure of screening young women for Chla-mydia trachomatis. Jt Comm J Qual Improv 2002; 28:435-440.
15. National Committee for Quality Assurance. HEDIS 2008: Technical Specifications. Washington, DC: National Committee for Quality Assurance; 2008.
16. Landis J, Koch G. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-174.
17. Civic D, Scholes D, Grothaus L, et al. Adolescent HMO enrollees' utilization of out-of-plan services. J Adolesc Health 2001; 28:491-496.
18. Head SK, Crosby RA, Shrier LA, et al. Young women's mis-perceptions about sexually transmissible infection testing: A 'clean and clear' misunderstanding. Sex Health 2007; 4:273-275.
19. Goodman K, Black CM, Persaud P, et al. Patient Knowledge of Sexually Transmitted Disease (STD) Testing in An Urban Clinic: A Comparison of Patient Perceived Testing and Actual Tests Performed. 2012 National STD Prevention Conference, Minneapolis. MN2012.
20. Head SK, Crosby RA, Moore GR. Pap smear knowledge among young women following the introduction of the HPV vaccine. J Pediatr Adolesc Gynecol 2009; 22:251-256.
21. Ogbechie OA, Hacker MR, Dodge LE, et al. Confusion regarding cervical cancer screening and chlamydia screening among sexually active young women. Sex Transm Infect 2012; 88:35-37.
22. Breitkopf CR, Pearson HC, Breitkopf DM. Poor knowledge regarding the Pap test among low-income women undergoing routine screening. Perspect Sex Reprod Health 2005; 37:78-84.
23. Royer HR, Falk EC, Heidrich SM. Sexually transmitted disease testing misconceptions threaten the validity of self-reported testing history. Public Health Nurs 2013; 30:117-127.